minulet 0,030mg/0,075mg obalená tableta
pfizer, spol. s r.o., praha array - 8280 gestoden; 578 ethinylestradiol - obalená tableta - 0,030mg/0,075mg - gestoden a ethinylestradiol
platel 75mg potahovaná tableta
medochemie ltd., limassol array - 3239 klopidogrel-sulfÁt - potahovaná tableta - 75mg - klopidogrel
ticagrelor viatris 60mg potahovaná tableta
viatris limited, dublin array - 17768 tikagrelor - potahovaná tableta - 60mg - tikagrelor
ticagrelor viatris 90mg potahovaná tableta
viatris limited, dublin array - 17768 tikagrelor - potahovaná tableta - 90mg - tikagrelor
tulip 40mg potahovaná tableta
lek pharmaceuticals d.d., ljubljana array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 40mg - atorvastatin
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogrel besilate - peripheral vascular diseases; stroke; myocardial infarction - antitrombotické činidla - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st elevace akutního infarktu myokardu, v kombinaci s asa u medikamentózně léčených pacientů vhodných pro trombolytickou terapii. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. pro další informace viz bod 5.
atoris 30mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 30mg - atorvastatin
atoris 60mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 60mg - atorvastatin
atoris 80mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 80mg - atorvastatin
donepezil viatris 10mg potahovaná tableta
viatris limited, dublin array - 14838 donepezil-hydrochlorid - potahovaná tableta - 10mg - donepezil